| pubmed-article:8192955 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8192955 | lifeskim:mentions | umls-concept:C0027651 | lld:lifeskim |
| pubmed-article:8192955 | lifeskim:mentions | umls-concept:C0007137 | lld:lifeskim |
| pubmed-article:8192955 | lifeskim:mentions | umls-concept:C0151546 | lld:lifeskim |
| pubmed-article:8192955 | lifeskim:mentions | umls-concept:C0521367 | lld:lifeskim |
| pubmed-article:8192955 | lifeskim:mentions | umls-concept:C1979874 | lld:lifeskim |
| pubmed-article:8192955 | lifeskim:mentions | umls-concept:C0237881 | lld:lifeskim |
| pubmed-article:8192955 | lifeskim:mentions | umls-concept:C0220901 | lld:lifeskim |
| pubmed-article:8192955 | lifeskim:mentions | umls-concept:C0750502 | lld:lifeskim |
| pubmed-article:8192955 | lifeskim:mentions | umls-concept:C2349975 | lld:lifeskim |
| pubmed-article:8192955 | lifeskim:mentions | umls-concept:C1627358 | lld:lifeskim |
| pubmed-article:8192955 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:8192955 | pubmed:dateCreated | 1994-6-28 | lld:pubmed |
| pubmed-article:8192955 | pubmed:abstractText | A retrospective analysis of the CT examinations of 45 patients with squamous cell carcinomas of the tongue, floor of the mouth and tongue base with long-term follow-up is presented. The aim of the study was to determine whether differences in tumor contrast enhancement and tumor demarcation at contrast-enhanced CT were correlated to prognosis in terms of posttreatment residual tumor or local recurrence. Ill-defined tumor margins were by means of multiple regression analysis significantly correlated to local failures (p = 0.043). This feature was, however, not associated with a significant decreased survival. The degree of tumor contrast enhancement did not parallel variations in the histopathologic composition of the tumors. | lld:pubmed |
| pubmed-article:8192955 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8192955 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8192955 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8192955 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8192955 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8192955 | pubmed:month | May | lld:pubmed |
| pubmed-article:8192955 | pubmed:issn | 0284-1851 | lld:pubmed |
| pubmed-article:8192955 | pubmed:author | pubmed-author:AspestrandFF | lld:pubmed |
| pubmed-article:8192955 | pubmed:author | pubmed-author:BoysenMM | lld:pubmed |
| pubmed-article:8192955 | pubmed:author | pubmed-author:EnghVV | lld:pubmed |
| pubmed-article:8192955 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8192955 | pubmed:volume | 35 | lld:pubmed |
| pubmed-article:8192955 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8192955 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8192955 | pubmed:pagination | 217-21 | lld:pubmed |
| pubmed-article:8192955 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:8192955 | pubmed:meshHeading | pubmed-meshheading:8192955-... | lld:pubmed |
| pubmed-article:8192955 | pubmed:meshHeading | pubmed-meshheading:8192955-... | lld:pubmed |
| pubmed-article:8192955 | pubmed:meshHeading | pubmed-meshheading:8192955-... | lld:pubmed |
| pubmed-article:8192955 | pubmed:meshHeading | pubmed-meshheading:8192955-... | lld:pubmed |
| pubmed-article:8192955 | pubmed:meshHeading | pubmed-meshheading:8192955-... | lld:pubmed |
| pubmed-article:8192955 | pubmed:meshHeading | pubmed-meshheading:8192955-... | lld:pubmed |
| pubmed-article:8192955 | pubmed:meshHeading | pubmed-meshheading:8192955-... | lld:pubmed |
| pubmed-article:8192955 | pubmed:meshHeading | pubmed-meshheading:8192955-... | lld:pubmed |
| pubmed-article:8192955 | pubmed:meshHeading | pubmed-meshheading:8192955-... | lld:pubmed |
| pubmed-article:8192955 | pubmed:meshHeading | pubmed-meshheading:8192955-... | lld:pubmed |
| pubmed-article:8192955 | pubmed:meshHeading | pubmed-meshheading:8192955-... | lld:pubmed |
| pubmed-article:8192955 | pubmed:meshHeading | pubmed-meshheading:8192955-... | lld:pubmed |
| pubmed-article:8192955 | pubmed:meshHeading | pubmed-meshheading:8192955-... | lld:pubmed |
| pubmed-article:8192955 | pubmed:meshHeading | pubmed-meshheading:8192955-... | lld:pubmed |
| pubmed-article:8192955 | pubmed:meshHeading | pubmed-meshheading:8192955-... | lld:pubmed |
| pubmed-article:8192955 | pubmed:meshHeading | pubmed-meshheading:8192955-... | lld:pubmed |
| pubmed-article:8192955 | pubmed:year | 1994 | lld:pubmed |
| pubmed-article:8192955 | pubmed:articleTitle | Prognostic significance of contrast enhancement and tumor demarcation at CT of squamous cell carcinomas of the oral cavity and oropharynx. | lld:pubmed |
| pubmed-article:8192955 | pubmed:affiliation | Department of Diagnostic Radiology, National Hospital, University of Oslo, Norway. | lld:pubmed |
| pubmed-article:8192955 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8192955 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
